2nd International Symposium and Advanced Course “Active Pharmaceutical Ingredients from Bioprocesses: from research to industrial and regulatory issues” APIB-2011 June 14-17, 2011 Salón de Actos “COFARES” Complutense University of Madrid Faculty of Pharmacy Plaza de Ramón y Cajal, s/n Madrid, Spain SCIENTIFIC PROGRAMME SCIENTIFIC WORKSHOP: RESEARCH AND DEVELOPMENT OF NEW BIOPROCESSES AND PRODUCTS Tuesday 14 June 2011 PL = Plenary lecture OP = Oral presentation IL = Invited lecture 14h00-17h30 Registration Opening Session 17h30-17h45 Opening Session: Welcome of the Authorities 17h45-18h00 Presentation of SEBIOT Prof. Andrés R. Alcántara, Complutense University of Madrid, Madrid, Spain 18h00-18h15 Presentation of the Congress: APIB-2011: Research, production and Quality of Active Pharmaceutical Ingredients Prof. Marco Terreni, University of Pavia; vice President of IBC; Pavia (Italy). Scientific Session-01: Peptide, Protein, Vaccine and Advanced Therapy (I) Chairman: Prof. Marco Terreni, University of Pavia, Pavia (Italy). 18h15-19:15 19h15-20h00 20h00- OPENING LECTURE(PL1): Needs and challenges for the development and GMP production of new biopharmaceuticals Speaker: Vitor Lino SOUSA Areta International; Gerenzano, Varese (Italy). IL1: Genomic technologies for identification and production of targets for vaccines and antibacterial therapy. Speaker: Eliora RON, Tel Aviv University; Tel Aviv (Israel): Welcome Cocktail: wine test from Spanish producer Wednesday 15 June 2011 Scientific Session-02: Peptide, Protein, Vaccine and Advanced Therapy (II) Chairman: Prof Flavia Marinelli; University of Insubria (Varese) Italy 9h30-10h30 10h.30-10.50 PL2: Synthetic Carbohydrate Vaccines. Speaker: . Peter H. SEEBERGER Max-Planck-Institute of Colloids and Interfaces. Potsdam-Golm. (Germany) OP1 Biotechnological approach for the rational design of new vaccines for TBC. Presentation of VATUB project. Speaker: Marco TERRENI, University of Pavia, Pavia (Italy) 10h50-11h30 Coffee Break 11h30-12h00 OP2: Biotechnology applications of recombinant DNA Speaker: Fedederico NININO, Università degli Studi di Udine. Udine (Italy) 12h00-12h30 OP3: Production of synthetic peptides as immunological probes for in vitro diagnostic assays Speaker: Paolo ROVERO; University of Florence, Sesto Fiorentino, Firenze (Italy) 12.h30-13h15 IL2: Plant thymidine kinases as suicide genes for anti-cancer therapy”. Speaker: Jure PISKUR, Lund University, Lund (Sweden) 13h15-14h30: Lunch 14h30-15h30: POSTERS Scientific Session-03: New and improved biocatalyst and enzymatic bioprocesses (I). Chairman: Prof. María J. HERNÁIZ, Complutense University of Madrid, Madrid, Spain. 15h30-16h45 16h45-17h15 17h15-17h45 17h45 IL3: Pichia pastoris as cell factory to produce recombinant proteins. Production and application of Rhizopu oryzae lipase. Speaker: Francisco VALERO; Autonoma University of Barcelona, Barcelona (Spain). OP4: Enzymatic synthesis of Vidarabine. Speaker: Immacolata SERRA, University of Pavia, Pavia (Italy). OP5: Preparation of (S)-benzoins using the non-conventional yeast Pichia glucozyma. Speaker: M.Caterina FRAGNELLI, University of Milan, (Italy) Closure of session 18h00-19h30 SEBIOT GENERAL ASSEMBLY 20h00 Guided Visit to Madrid and Social Dinner Thursday 16 June 2011 Scientific Session-04: New and improved biocatalyst and enzymatic bioprocesses (II). Chairman: Prof. Paolo ROVERO; University of Florence, Sesto Fiorentino (Firenze), Italy 09h30-10h15 IL4: Enzymologists in wonderland: new biotech applications from evolved D-amino acid oxidases. Speaker: Prof. Loredano POLLEGIONI; University of Insubria, Varese, (Italy). 10h15-110h45 OP6: Immobilised L-Amino acid acylase and N-Acetyl amino acid racemase for L-methionine production. Speaker: Ulrich E. GIESECKE, W42 Consulting GmbH, Penzberg (Germany). 10h45-11h15 OP7: Chemoenzymatic synthesis of unsymmetrical benzoins, useful drug intermediates, via dynamic kinetic resolution. Speaker: Pilar HOYOS, Complutense University of Madrid, Madrid (Spain). 11h15-11h45 Coffee Break 11h45-12h15 12h15-12h45 12h45-13h15 OP8: PHB depolymerases from Streptomyces for production of high added value compounds. Speaker: Miguel ARROYO, Complutense University of Madrid, Spain. OP9: Modulating resveratrol solubility and surfactant activity by enzymatic glucosylation. Speaker: Pamela TORRES, Instituto de Catálisis y Petroleoquímica (CSIC) Madrid, (Spain). OP10: Chemoenzymatic synthesis of high quality testosterone. Speaker: Riccardo MOTTERLE, F.I.S. Fabbrica Italiana Sintetici S.p.A., Vicenza, (Italy). 13h15-14h30: Lunch 14h30-15h30: POSTERS Scientific Session-05: Biosynthesis and semi-synthesis of APIs and nutraceutics Chairman: Prof. Francisco VALERO; Autonoma University of Barcelona, Spain. 15h30-16h30 16h30-17h00 17h00-17h30 17h30-18h00 18h00 PL3: Marine Biodiversity & Biotechnology as source of innovative anticancer drugs. The experience of PharmaMar. Speaker: Fernando DE LA CALLE, PharmaMar, S.A. Colmenar Viejo, Madrid (Spain): OP11: Modulation of complex composition in fermentative industrial production of glycopeptides. Speaker: Flavia MARINELLI, University of Insubria; Varese; (Italy) OP12: Enzymatic modification of glycolipopeptides. Speaker: Francesco Molinari; Università degli Studi di Milano; Milano (Italy) OP13: Improved method for the extraction of licopene from tomato processing waste: development and scale up. Speaker: M. Argnani, Biosphere SpA, Bertinoro (Forlì Cesena), Italy. CLOSING OF THE SYMPOSIUM Friday 17-June 2011 ADVANCED COURSE: INDUSTRIAL BIOPROCESSES AND QUALITY OF ACTIVE INGREDIENTS 09h30-10h15 Quality of biotechnological products and biosimilars. Dr. Sol Ruiz; Spanish agency of medicinal products-AEMPS; Madrid; (Spain) 10h15-11h00 Second generation vaccines: the long way to the market. Dr. Carmen VELA; Ingenasa; Madrid (Spain). 11h00-11h30 Coffee Break 11h30-12h10 Registration of biological medicinal products in EU: a regulatory perspective. Dr. Carla Martino, European Medicinal Agency; London (England). 12h10-12h50 Relevant GMP aspects of the industrial manufacture of biotechnology products from the inspector’s perspective. Dr. Manuel IBARRA LORENTE, Spanish agency of medicinal products (AEMPS) Madrid; (Spain) 12h50-13h30 The Ph. Eur and the monographs for fermentation products, peptides and biologicals – general concepts and practical examples. Dr. Helene BRUGUERA, EDQM, Council of Europe; Strasbourg; (France) 13h30-14h45 Lunch 14h45 -15h15 Basic procedures and controls for fermentation processes. Prof. Francesco MOLINARI (Università degli Studi di Milano, Milan (Italy) 15h15-16h00 Biotransformation and quality of Active Pharmaceutical Ingredient. Prof. Marco TERRENI; University of Pavia; Pavia, (Italy) 16h00-16h30 Coffee Break 16h30-17h10 GMP and Quality Risk Management Process for multi product on fermentation and microfiltration equipment Case study from class B1 product to other products. Dr. Fulvio CARLOTTI; Gnosis S.p.a; Desio; Monza Brianza (Italy) 17h10-17h40 Quality problems for APIs used in essential medicines for developing countries: role of WHO and its pre-qualification programme. Corinne POUGET; Consultant, Castres; (France) 17h40 Closure of the Course